Related Experiment Video

Updated: Jun 25, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP

Yifeng Xia1, Roanna C Padre, Tatiana Hurtado De Mendoza

  • 1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 7, 2009
PubMed

Insights

IkappaB kinase 2 (IKK2) and beta-transducin repeat-containing protein 1 (beta-TrCP1) regulate p53 stability by phosphorylating and ubiquinating p53, respectively. Targeting IKK2 and beta-TrCP1 may offer new cancer therapy strategies by controlling p53 activity.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • The NF-kappaB pathway is constitutively activated in many human cancers.
  • p53 is a tumor suppressor frequently inactivated in cancer.
  • IKK2 is essential for NF-kappaB activation.

Purpose of the Study:

  • To investigate the role of IKK2 in p53 regulation.
  • To identify novel regulators of p53 stability and degradation.
  • To explore potential therapeutic targets for cancer treatment.

Main Methods:

  • Phosphorylation site mapping of p53.
  • Ubiquitination assays.
  • siRNA-mediated knockdown of IKK2 and beta-TrCP1.
  • Analysis of p53 target gene expression (e.g., p21).
  • Cell cycle analysis.

Main Results:

  • IKK2 directly phosphorylates p53 at Ser-362 and Ser-366.
  • Phosphorylated p53 is ubiquitinated by beta-TrCP1 and degraded independently of Mdm2.
  • Reduction of beta-TrCP1 levels or inhibition of its function stabilizes p53.
  • Mutating Ser-362 and Ser-366 to alanine enhances p53 stability and activity.
  • p53 stabilization leads to increased p21 expression and cell cycle alterations.

Conclusions:

  • IKK2 and beta-TrCP1 are novel regulators of p53 stability.
  • The IKK2-beta-TrCP1 axis controls p53 degradation.
  • Inhibition of IKK2 or beta-TrCP1 can stabilize p53 and modulate its tumor-suppressive functions.
  • This pathway represents a potential therapeutic target for cancers with dysregulated p53 and NF-kappaB signaling.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...